world is news

Unichem Labs will get American drug regulator’s nod to market generic Celecoxib capsules, Health News, ET HealthWorld

Spread the news

NEW DELHI: Drug agency Unichem Laboratories on Wednesday mentioned it has obtained approval from the US well being regulator to market its generic Celecoxib capsules used for therapy of osteoarthritis, rheumatoid arthritis and acute ache. The firm has obtained abbreviated new drug software (ANDA) approval for its Celecoxib capsules within the strengths of 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (USFDA), Unichem mentioned in a submitting to BSE.

The capsules are generic variations of GD Searle LLC’s Celebrex capsules in the identical strengths, it added.

The product shall be commercialized from the corporate’s Goa plant, the submitting mentioned.

“Celecoxib capsules are indicated for treatment of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, acute pain and primary dysmenorrhea,” it added.

Shares of Unichem Laboratories have been buying and selling at Rs 280.55 per scrip on BSE, up 1.04 per cent from its earlier shut.

Spread the news